Malignant CTCL cells have been shown to induce FasL-mediated T cell apoptosis in vitro, and the numbers of CD8+ T cells are inversely distributed with FasL-positive tumor cells in situ, supporting that the malignant T cells utilize FasL to kill tumor-reactive T cells [102, 103]. The gene discussed is FASLG; the disease is neoplasm.